Trial · NCT01674712
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Change of TG (Triglyceride) | from baseline to 12 weeks of treatment | Collection and measurement of blood samples. |
| Primary | Percentage of Change of HDL-C (High Density Lipoprotein Cholesterol) | from baseline to 12 weeks of treatment | Collection and measurement of blood samples. |
| Primary | Percentage of Change of LDL-C (Low Density Lipoprotein Cholesterol) | from baseline to 12 weeks of treatment | Collection and measurement of blood samples. |
| Secondary | Percentage of Non-HDL (High Density Lipoprotein)-C From Baseline | 12 weeks | Collection and measurement of blood samples |
| Secondary | Percentage of TC (Triglyceride) From Baseline | 12 weeks | Collection and measurement of blood samples |
| Secondary | Percentage of Apolipoprotein AI From Baseline | 12 weeks | Collection and measurement of blood samples |
| Secondary | Percentage of Apolipoprotein B From Baseline | 12 weeks | Collection and measurement of blood samples |
| Secondary | Percentage of High-sensitivity C-reactive Protein (hsCRP) From Baseline | 12 weeks | Collection and measurement of blood samples |
| Secondary | Percentage of Subjects Meeting Target Levels of Lipids (According to Very High or High Risk) | 12 weeks | Collection and measurement of blood samples |
| Secondary | Adverse Events | 12 weeks | Collection and measurement of blood samples |
| Secondary | Creatine Kinase (CK) | 12 weeks | Collection and measurement of blood samples |
| Secondary | Alanine Aminotransferase (ALT) | 12 weeks | Collection and measurement of blood samples |
| Secondary | Plasma Creatinine | 12 weeks | Collection and measurement of blood samples |
| Secondary | Total Bilirubin | 12 weeks | Collection and measurement of blood samples |
| Secondary | Cystatin C | 12 weeks | Collection and measurement of blood samples |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01674712/registered